Annette Powers

452 total citations
18 papers, 317 citations indexed

About

Annette Powers is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Psychiatry and Mental health. According to data from OpenAlex, Annette Powers has authored 18 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pediatrics, Perinatology and Child Health, 5 papers in Oncology and 5 papers in Psychiatry and Mental health. Recurrent topics in Annette Powers's work include Epilepsy research and treatment (5 papers), Pharmacological Effects and Toxicity Studies (5 papers) and CAR-T cell therapy research (4 papers). Annette Powers is often cited by papers focused on Epilepsy research and treatment (5 papers), Pharmacological Effects and Toxicity Studies (5 papers) and CAR-T cell therapy research (4 papers). Annette Powers collaborates with scholars based in United States, United Kingdom and Australia. Annette Powers's co-authors include Michael S. Broder, Dasha Cherepanov, Joyce A. Cramer, Ronda Copher, Eunice Chang, Zhixiao Wang, David G. Maloney, Safiya Abouzaid, Nathan L. Kleinman and Jacob Garcia and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Annette Powers

17 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annette Powers United States 9 158 148 59 34 31 18 317
Bong-Chul Chu United States 13 120 0.8× 93 0.6× 41 0.7× 115 3.4× 35 1.1× 22 477
Pamela Landsman‐Blumberg United States 11 32 0.2× 55 0.4× 44 0.7× 31 0.9× 52 1.7× 34 302
Jesse Fishman United States 10 119 0.8× 102 0.7× 8 0.1× 64 1.9× 20 0.6× 50 405
Aparna Chatterjee India 11 19 0.1× 73 0.5× 34 0.6× 38 1.1× 43 1.4× 50 294
Lesa Dawman India 11 91 0.6× 66 0.4× 35 0.6× 21 0.6× 43 1.4× 66 435
Susanna Timonen Finland 11 26 0.2× 131 0.9× 40 0.7× 23 0.7× 68 2.2× 25 290
Joanna Pierro United States 9 165 1.0× 160 1.1× 91 1.5× 49 1.4× 68 2.2× 17 391
Jesús Tornero Molina Spain 12 55 0.3× 21 0.1× 16 0.3× 22 0.6× 68 2.2× 34 438
Diane Portman United States 11 48 0.3× 123 0.8× 73 1.2× 12 0.4× 141 4.5× 37 353
Paola Verdecchia Italy 9 99 0.6× 26 0.2× 15 0.3× 116 3.4× 34 1.1× 16 314

Countries citing papers authored by Annette Powers

Since Specialization
Citations

This map shows the geographic impact of Annette Powers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette Powers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette Powers more than expected).

Fields of papers citing papers by Annette Powers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette Powers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette Powers. The network helps show where Annette Powers may publish in the future.

Co-authorship network of co-authors of Annette Powers

This figure shows the co-authorship network connecting the top 25 collaborators of Annette Powers. A scholar is included among the top collaborators of Annette Powers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette Powers. Annette Powers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Matza, Louis S., et al.. (2022). Health State Utilities for Adverse Events Associated with Chimeric Antigen Receptor T-Cell Therapy in Large B-Cell Lymphoma. PharmacoEconomics - Open. 6(3). 367–376. 11 indexed citations
2.
Patrick, Donald L., Annette Powers, Yeonhee Kim, et al.. (2021). Effect of lisocabtagene maraleucel on HRQoL and symptom severity in relapsed/refractory large B-cell lymphoma. Blood Advances. 5(8). 2245–2255. 25 indexed citations
3.
4.
5.
Cramer, Joyce A., Eunice Chang, Annette Powers, et al.. (2014). Healthcare utilization and costs in children with stable and uncontrolled epilepsy. Epilepsy & Behavior. 32. 135–141. 49 indexed citations
6.
Kleinman, Nathan L., et al.. (2014). Cohort Analysis Assessing Medical and Nonmedical Cost Associated With Obesity in the Workplace. Journal of Occupational and Environmental Medicine. 56(2). 161–170. 35 indexed citations
7.
Wang, Zhixiao, Xuan Li, Annette Powers, & José E Cavazos. (2014). Outcomes associated with switching from monotherapy to adjunctive therapy for patients with partial onset seizures. Expert Review of Pharmacoeconomics & Outcomes Research. 15(2). 349–355. 8 indexed citations
8.
Broder, Michael S., et al.. (2014). The Impact of 5-HT3RA Use on Cost and Utilization in Patients with Chemotherapy-Induced Nausea and Vomiting: Systematic Review of the Literature.. PubMed. 7(3). 171–82. 11 indexed citations
9.
Abouzaid, Safiya, et al.. (2013). Cohort analysis assessing medical and non-medical cost associated with obesity in the Workplace. Value in Health. 16(3). A9–A9. 2 indexed citations
10.
Cramer, Joyce A., Eunice Chang, Annette Powers, et al.. (2013). Healthcare utilization and costs in adults with stable and uncontrolled epilepsy. Epilepsy & Behavior. 31. 356–362. 122 indexed citations
11.
Faria, Claudio, Xuan Li, Annette Powers, & Linda T. Vahdat. (2013). Effects of dose modification of eribulin mesylate in patients with locally recurrent or metastatic breast cancer.. Journal of Clinical Oncology. 31(26_suppl). 157–157. 1 indexed citations
12.
Cramer, Joyce A., et al.. (2012). PND15 Health Care Resource Utilization and Expenditures of Epilepsy in Pediatric and Adult Medicaid Population. Value in Health. 15(4). A143–A143. 3 indexed citations
13.
Cramer, Joyce A., et al.. (2012). Antiepileptic Drug Use Patterns in the Pediatric and Adult Medicaid Population (P06.110). Neurology. 78(Meeting Abstracts 1). P06.110–P06.110.
14.
Powers, Annette, Claudio Faria, Michael S. Broder, Eunice Chang, & Dasha Cherepanov. (2012). Hematologic complications, healthcare utilization, and costs in commercially insured patients with myelodysplastic syndrome receiving supportive care.. PubMed. 5(7). 455–65. 5 indexed citations
15.
Schilling, Brian J., et al.. (2011). PCV32 BUDGET IMPACT ANALYSIS OF INCREASING LMWH/FXI UTILIZATION. Value in Health. 14(3). A38–A38. 1 indexed citations
16.
Stein, K. Viktoria, et al.. (2011). Relationship between age and health care utilization in patients with myelodysplastic syndrome receiving supportive care.. Journal of Clinical Oncology. 29(15_suppl). 6560–6560. 1 indexed citations
17.
Simons, W. Robert, et al.. (2011). Comparative Effectiveness of Dalteparin and Enoxaparin in a Hospital Setting. Journal of Pharmacy Practice. 25(2). 180–189. 2 indexed citations
18.
Juday, Timothy, Hong Tang, Melissa Harris, et al.. (2010). Adherence to Chronic Hepatitis B Treatment Guideline Recommendations for Laboratory Monitoring of Patients Who Are Not Receiving Antiviral Treatment. Journal of General Internal Medicine. 26(3). 239–244. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bong-Chul Chu Breakdown of academic impact, for papers by Pamela Landsman‐Blumberg Breakdown of academic impact, for papers by Jesse Fishman Breakdown of academic impact, for papers by Aparna Chatterjee Breakdown of academic impact, for papers by Lesa Dawman Breakdown of academic impact, for papers by Susanna Timonen Breakdown of academic impact, for papers by Joanna Pierro Breakdown of academic impact, for papers by Jesús Tornero Molina Breakdown of academic impact, for papers by Diane Portman Breakdown of academic impact, for papers by Paola Verdecchia
Rankless by CCL
2026